BERMAN ROBERT ANDREW (Chief Executive Officer) purchased 1.2% of their position (2.50K shares) of ENVVENO MEDICAL CORP on the open market
Open‑market purchase worth $9.5K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/28/2022ACC: 0001493152-22-017957
DirectorOfficer· Chief Executive Officer
Since Sep 2018
+2.50K
Net shares
Net buyer
$9.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.50K
Price / share
$3.80
Trade value
$9.50K
% of position
1.2%
6/27/2022
207.74K→210.24K
Total
Net shares
+2.50K
Net value
$9.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/27/2022 | P · Purchase | +2.50K | $3.80 | $9.50K | 1.2% | 207.74K | 210.24K |
| Total | +2.50K | $9.50K | ||||||
Derivative Transactions0
No derivative transactions reported